Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Emilio Ansotegui"'
Autor:
Javier, Simarro, Gema, Pérez-Simó, Nuria, Mancheño, Emilio, Ansotegui, Carlos Francisco, Muñoz-Núñez, José, Gómez-Codina, Óscar, Juan, Sarai, Palanca
Publikováno v:
International journal of molecular sciences. 23(15)
In pretreatment tumor samples of
Autor:
Oscar Juan, Sarai Palanca, C. Jordá, Antonio Cremades, Emilio Ansotegui, José J. Cerón, Carolina Gandía, Rosa Farràs, José Miguel Pardo-Sánchez, Nuria Mancheño
Publikováno v:
Cancers
Cancers, Vol 13, Iss 2980, p 2980 (2021)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Volume 13
Issue 12
r-FISABIO. Repositorio Institucional de Producción Científica
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)
Cancers, Vol 13, Iss 2980, p 2980 (2021)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Volume 13
Issue 12
r-FISABIO. Repositorio Institucional de Producción Científica
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)
Simple Summary Advances have been made in the study of NSCLC tumors using in vivo models, such as patient-derived xenografts (PDXs). However, the number of PDX models that can represent the heterogeneity of NSCLC between different individuals is stil
Autor:
Cristina Berastegui, Jordi Dorca, Claudia Valenzuela, Julio Ancochea, Pilar Hereu, Carmen Herranz, Salud Santos, Guadalupe Bermudo, Patricio Luburich, Piedad Ussetti, José Antonio Rodríguez-Portal, Antonio Roman, Vanesa Vicens-Zygmunt, Rosalía Laporta, Miquel Àngel Pujana Sharing Senior Position, Emilio Ansotegui, Jaume Bordas-Martinez, Álvaro Casanova, Roger Llatjós, Maria Molina-Molina Sharing Senior Position
Publikováno v:
Rare ILD / DPLD.
Introduction: LAM is a rare and lethal disease characterized by progressive cystic lung destruction. Inhibition of mTOR with rapamycin is the current standard of care, which can slow-down disease. Plasma major histamine metabolite (Methylimidazoleace
Autor:
Sarai Palanca, Oscar Juan, Nuria Mancheño, C. Jordá, Antonio Cremades, José J. Cerón, Emilio Ansotegui, Carolina Gandía, José Miguel Pardo-Sánchez, Rosa Farràs
Publikováno v:
Cancers, Vol 13, Iss 4825, p 4825 (2021)
The authors would like to make a correction to their published paper [...]
Autor:
Sarai Palanca, Javier Simarro, Marta Llop, Rosa Murria, Emilio Ansotegui, Nuria Mancheño, Oscar Juan, Carmen Salvador, Eva Barragán, Enrique Cases, David Ramos, Gema Perez-Simó, Inmaculada de Juan, Begoña Laiz, Jorge Aparicio, José Gómez-Codina
Publikováno v:
Cancers
Volume 11
Issue 8
Cancers, Vol 11, Iss 8, p 1196 (2019)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Volume 11
Issue 8
Cancers, Vol 11, Iss 8, p 1196 (2019)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
The establishment of precision medicine in cancer patients requires the study of several biomarkers. Single-gene testing approaches are limited by sample availability and turnaround time. Next generation sequencing (NGS) provides an alternative for d
Autor:
Gerard Muñoz, Montserrat Vendrell, Beatriz Montull, Carolina Cisneros, Rosario Menéndez, Emilio Ansotegui, Rosa Girón, Victoria Alcaraz-Serrano, Antoni Torres, Eva Polverino, Mariana Benegas, Marcelo Sánchez, Edmundo Rosales-Mayor, Maria Angeles Marcos
Publikováno v:
JOURNAL OF INFECTION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Objectives: Despite the clinical relevance of exacerbations in bronchiectasis (BE), little is known about the microbiology and outcomes of pneumonic (CAP) vs. non-pneumonic (NOCAP) exacerbations. Methods: This study compares clinical and microbiologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680a4c91d08475c3e6cb73cb21d2757f
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8188
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8188
Autor:
Maria Angeles Menéndez Salinas, Dolores Nauffal Manzur, Alberto Garcia Ortega, Raquel López Reyes, Begoña Balerdi Perez, Emilio Ansotegui Barrera
Publikováno v:
The Clinical Respiratory Journal. 11:103-112
Background and Aims The aim of our study was to describe the characteristics and clinical outcomes of pulmonary hypertension (PH) patients who underwent their follow-up at a single centre. Methods We included patients who fulfilled the criteria for t
Autor:
Soledad Reyes, Edmundo Rosales, Emilia Isabel Amara Elori, Beatriz Montull, Antoni Torres, Emilio Ansotegui, Eva Polverino, Rosalen Amaro, Tomás Posadas, Alexandra Gimeno, Rosario Menéndez, Raúl Méndez
Publikováno v:
Respiratory Infections.
Background: Non-cystic fibrosis bronchiectasis (BE) is a chronic lung disease characterized by permanent dilatation of airways with chronic infection and inflammation that leads to frequent infectious exacerbations. There is a lack of information abo
Autor:
Claudia Valenzuela, Masaki Hirose, Maria Molina-Molina, Piedad Ussetti, Olivier Nuñez, José I. López, Fina Climent, Yoshikazu Inoue, Manel Esteller, Gorka Ruiz de Garibay, Álvaro Casanova, Anna Petit, Rosalía Laporta, Raul Ortega, Nadia García, Emilio Ansotegui, Jacopo Boni, Gema Bueno-Moreno, Antonio Roman, María Jesús Pla, Simon R. Johnson, Francesca Mateo, A Guma, Marina Pollán, Teresa Soler, August Vidal, Antoni Xaubet, Jose V. Sanchez-Mut, Miriam Campos, Carmen Herranz, Julio Ancochea, Miguel Angel Pujana
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repisalud
Instituto de Salud Carlos III (ISCIII)
Digital.CSIC. Repositorio Institucional del CSIC
instname
BREAST CANCER RESEARCH AND TREATMENT
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Breast Cancer Research and Treatment
Consejería de Sanidad de la Comunidad de Madrid
Repisalud
Instituto de Salud Carlos III (ISCIII)
Digital.CSIC. Repositorio Institucional del CSIC
instname
BREAST CANCER RESEARCH AND TREATMENT
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Breast Cancer Research and Treatment
This article is published with open access at Springerlink.com.-- et al.
Molecular evidence has linked the pathophysiology of lymphangioleiomyomatosis (LAM) to that of metastatic breast cancer. Following on this observation, we assessed the asso
Molecular evidence has linked the pathophysiology of lymphangioleiomyomatosis (LAM) to that of metastatic breast cancer. Following on this observation, we assessed the asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29c60f74b0704330e9eca8c6f9a7cfeb
https://ddd.uab.cat/record/185820
https://ddd.uab.cat/record/185820
Autor:
Raquel, López Reyes, Dolores, Nauffal Manzur, Alberto, Garcia Ortega, Maria Angeles, Menéndez Salinas, Emilio, Ansotegui Barrera, Begoña, Balerdi Perez
Publikováno v:
The clinical respiratory journal. 11(1)
The aim of our study was to describe the characteristics and clinical outcomes of pulmonary hypertension (PH) patients who underwent their follow-up at a single centre.We included patients who fulfilled the criteria for the diagnosis of PH by right h